CN Patent

CN118903430A — PI3K/Akt在制备预防缓解或治疗血虚症药物中的应用

Assigned to Tsing Hua De Ren Xi'an Happiness Pharmaceutical Co ltd · Expires 2024-11-08 · 2y expired

What this patent protects

本发明提供PI3K/Akt在制备治疗血虚症药物中的应用。本发明发现PI3K/Akt通路的新功能，即激活PI3K/Akt通路，可以升高造血因子表达，抑制肾脏炎症因子、提高Bcl‑2表达的作用。基于PI3K/Akt在预防、缓解和/或治疗血虚症中的作用，其可以用于制备预防、缓解和/或治疗血虚症的药物。

USPTO Abstract

本发明提供PI3K/Akt在制备治疗血虚症药物中的应用。本发明发现PI3K/Akt通路的新功能，即激活PI3K/Akt通路，可以升高造血因子表达，抑制肾脏炎症因子、提高Bcl‑2表达的作用。基于PI3K/Akt在预防、缓解和/或治疗血虚症中的作用，其可以用于制备预防、缓解和/或治疗血虚症的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN118903430A
Jurisdiction
CN
Classification
—
Expires
2024-11-08
Drug substance claim
No
Drug product claim
No
Assignee
Tsing Hua De Ren Xi'an Happiness Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.